LifeTech Scientific (HKG:1302) said Ankura Aortic Stent Graft System received official registration approval
from the China National Medical Products Administration (NMPA), according to a Wednesday filing with the Hong Kong bourse.
The system was jointly developed by Professor Shu Chang of Fuwai Hospital, Chinese Academy of Medical Sciences, and the Group. The system is an aortic stent graft system designed for the chimney technique, offering an effective treatment for aortic arch lesions with broad anatomical compatibility.